Inflammatory bowel disease is rare in the Chinese population.
It has been suggested that this results in limited support, misinformation, unalleviated fears and adversely affected quality of life (QOL) in Chinese IBD patients.
Researchers from Hong Kong and Australia compared the inflammatory bowel disease (IBD)-related knowledge, QOL, and use of complementary and alternative medicines and therapies (CAMT) in two contrasting IBD populations.
The research group gave questionnaires on IBD knowledge and CAMT usage to Chinese and Caucasian IBD patients.
The group used the validated Inflammatory Bowel Disease Questionnaire in order to assess QOL.
In total, the researchers recruited 162 IBD patients, of those, 81 were Chinese and 81 Caucasian.
The researchers found that the IBD knowledge score was higher in Caucasian than in Chinese IBD patients and it was independent of education and occupation.
|IBD-related knowledge was inferior in Chinese compared to Caucasian IBD patients|
|Digestive Diseases and Sciences|
In addition, 21% of Chinese subjects incorrectly identified their IBD type in contrast with 0% in the Caucasian group.
QOL was higher in the Chinese than the Caucasian group, but not significantly different after adjusting for disease activity.
QOL was unassociated with IBD knowledge.
The research group found that the overall use of CAMT was similar in both groups (33% of Chinese and 37% of Caucasian patients) and similar for Crohn's disease and ulcerative colitis.
Jillian Philpott concluded, "IBD-related knowledge was inferior in Chinese compared to Caucasian IBD patients."
"Health-related QOL is unlikely to be greatly influenced by disease-related knowledge or education."
"A high proportion of Chinese and Caucasian IBD patients use CAMT."